Can BRCA genes predict early menopause? new study seeks answers

NCT ID NCT00823654

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how BRCA gene mutations and breast cancer treatments affect the ovaries in premenopausal women. Researchers will measure hormone levels in the blood before, during, and after cancer therapy to understand the risk of early menopause and fertility problems. About 609 women with early-stage breast cancer or high-risk BRCA mutations will participate. The goal is to learn which women are more likely to experience early menopause, helping guide future family planning decisions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Memorial Sloan Kettering Basking Ridge

    RECRUITING

    Basking Ridge, New Jersey, United States

  • Memorial Sloan Kettering Bergen

    RECRUITING

    Montvale, New Jersey, 07645, United States

  • Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 10065, United States

  • Memorial Sloan Kettering Commack

    RECRUITING

    Commack, New York, 11725, United States

  • Memorial Sloan Kettering Monmouth

    RECRUITING

    Middletown, New Jersey, 07748, United States

  • Memorial Sloan Kettering Nassau

    RECRUITING

    Uniondale, New York, 11553, United States

  • Memorial Sloan Kettering Westchester

    RECRUITING

    Harrison, New York, 10604, United States

  • New York Presbyterian Hospital-Weill Medical College of Cornell University

    ACTIVE_NOT_RECRUITING

    New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.